Standard Biotools (LAB) Assets Average (2011 - 2026)

Standard Biotools (LAB) has 16 years of Assets Average data on file, last reported at $603.4 million in Q1 2026.

• Quarterly Assets Average rose 1.25% year-over-year to $603.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $603.4 million (up 1.25% YoY) and the FY2025 annual result came in at $590.0 million, up 26.16% from the prior year.
• Assets Average grew to $603.4 million in Q1 2026 per LAB's latest filing, from $553.7 million in the prior quarter.
• Across five years, Assets Average topped out at $743.2 million in Q2 2024 and bottomed at $273.6 million in Q1 2022.
• The 5-year median for Assets Average is $548.3 million (2025), against an average of $493.5 million.
• The widest annual swing landed in 2024, when Assets Average soared 104.32%; it then declined 23.54% in 2025.
• Tracing LAB's Assets Average over 5 years: stood at $402.6 million in 2022, then dropped by 17.74% to $331.2 million in 2023, then soared by 95.35% to $646.9 million in 2024, then decreased by 14.41% to $553.7 million in 2025, then gained by 8.98% to $603.4 million in 2026.
• Per Business Quant, the three latest LAB Assets Average figures stand at $603.4 million (Q1 2026), $553.7 million (Q4 2025), and $548.3 million (Q3 2025).

Peer Comparison